Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Bos taurus | Adenosine A1 receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma japonicum | ko:K04209 neuropeptide Y receptor, invertebrate, putative | Adenosine A1 receptor | 326 aa | 318 aa | 22.3 % |
Schistosoma japonicum | 5-hydroxytryptamine receptor 4, putative | Adenosine A1 receptor | 326 aa | 301 aa | 25.6 % |
Schistosoma mansoni | peptide (allatostatin)-like receptor | Adenosine A1 receptor | 326 aa | 312 aa | 24.0 % |
Loa Loa (eye worm) | hypothetical protein | Adenosine A1 receptor | 326 aa | 296 aa | 22.6 % |
Schistosoma mansoni | neuropeptide receptor | Adenosine A1 receptor | 326 aa | 277 aa | 23.8 % |
Echinococcus multilocularis | allatostatin A receptor | Adenosine A1 receptor | 326 aa | 306 aa | 26.1 % |
Schistosoma mansoni | opsin-like receptor | Adenosine A1 receptor | 326 aa | 312 aa | 22.1 % |
Onchocerca volvulus | Ubiquinol-cytochrome-c reductase complex assembly factor 1 homolog | Adenosine A1 receptor | 326 aa | 286 aa | 22.7 % |
Onchocerca volvulus | Adenosine A1 receptor | 326 aa | 326 aa | 20.2 % | |
Onchocerca volvulus | Adenosine A1 receptor | 326 aa | 311 aa | 21.9 % | |
Schistosoma mansoni | neuropeptide receptor | Adenosine A1 receptor | 326 aa | 314 aa | 21.7 % |
Loa Loa (eye worm) | neuropeptide F receptor | Adenosine A1 receptor | 326 aa | 316 aa | 19.3 % |
Schistosoma japonicum | ko:K04134 cholinergic receptor, invertebrate, putative | Adenosine A1 receptor | 326 aa | 331 aa | 25.7 % |
Brugia malayi | hypothetical protein | Adenosine A1 receptor | 326 aa | 311 aa | 21.9 % |
Schistosoma mansoni | opsin-like receptor | Adenosine A1 receptor | 326 aa | 315 aa | 23.8 % |
Echinococcus granulosus | allatostatin A receptor | Adenosine A1 receptor | 326 aa | 304 aa | 25.3 % |
Onchocerca volvulus | Adenosine A1 receptor | 326 aa | 307 aa | 21.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0064 | 0.3137 | 0.3137 |
Brugia malayi | glutamine synthetase | 0.0047 | 0.1397 | 0.1954 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0043 | 0.0975 | 0.0975 |
Schistosoma mansoni | thyroid hormone receptor | 0.0043 | 0.0975 | 0.0975 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0064 | 0.3137 | 1 |
Wolbachia endosymbiont of Brugia malayi | glutamine synthetase | 0.0033 | 0 | 0.5 |
Onchocerca volvulus | 0.0064 | 0.3137 | 0.5085 | |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0064 | 0.3137 | 0.2396 |
Toxoplasma gondii | glutamine synthetase, type I, putative | 0.0085 | 0.5227 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0064 | 0.3137 | 0.3137 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0064 | 0.3137 | 1 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0064 | 0.3137 | 0.2396 |
Schistosoma mansoni | thyroid hormone receptor | 0.0043 | 0.0975 | 0.0975 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0064 | 0.3137 | 0.2396 |
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.0043 | 0.0975 | 0.0975 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0064 | 0.3137 | 0.2396 |
Trypanosoma cruzi | glutamine synthetase, putative | 0.0132 | 1 | 0.5 |
Schistosoma mansoni | steroid hormone receptor ad4bp | 0.0043 | 0.0975 | 0.0975 |
Schistosoma mansoni | nuclear hormone receptor nor-1/nor-2 | 0.0043 | 0.0975 | 0.0975 |
Leishmania major | glutamine synthetase, putative | 0.0132 | 1 | 0.5 |
Mycobacterium leprae | PROBABLE GLUTAMINE SYNTHETASE GLNA2 (GLUTAMINE SYNTHASE) (GS-II) | 0.0085 | 0.5227 | 0.5 |
Loa Loa (eye worm) | brahma associated protein | 0.0064 | 0.3137 | 0.5085 |
Schistosoma mansoni | RAR-like nuclear receptor | 0.0043 | 0.0975 | 0.0975 |
Mycobacterium ulcerans | glutamine synthetase GlnA1 | 0.0085 | 0.5227 | 1 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0064 | 0.3137 | 0.2396 |
Schistosoma mansoni | nuclear hormone receptor | 0.0043 | 0.0975 | 0.0975 |
Loa Loa (eye worm) | Gln-2 protein | 0.0085 | 0.5227 | 1 |
Chlamydia trachomatis | SWIB complex protein | 0.0064 | 0.3137 | 0.5 |
Onchocerca volvulus | Glutamine synthetase homolog | 0.0085 | 0.5227 | 1 |
Schistosoma mansoni | FTZ-F1 nuclear receptor-like protein | 0.0043 | 0.0975 | 0.0975 |
Trypanosoma cruzi | glutamine synthetase, putative | 0.0132 | 1 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.0064 | 0.3137 | 1 |
Schistosoma mansoni | brg-1 associated factor | 0.0064 | 0.3137 | 0.3137 |
Brugia malayi | brahma associated protein 60 kDa | 0.0064 | 0.3137 | 1 |
Entamoeba histolytica | glutamine synthetase, putative | 0.0033 | 0 | 0.5 |
Echinococcus multilocularis | glutamine synthetase | 0.0132 | 1 | 1 |
Schistosoma mansoni | coup transcription factor | 0.0043 | 0.0975 | 0.0975 |
Trypanosoma brucei | glutamine synthetase, putative | 0.0132 | 1 | 0.5 |
Plasmodium falciparum | glutamine synthetase, putative | 0.0085 | 0.5227 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0064 | 0.3137 | 0.3137 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0064 | 0.3137 | 0.5 |
Schistosoma mansoni | glutamine synthetase 1 2 (glutamate-amonia ligase) (gs) | 0.0132 | 1 | 1 |
Schistosoma mansoni | nuclear receptor 2DBD-gamma | 0.0043 | 0.0975 | 0.0975 |
Plasmodium vivax | glutamine synthetase, putative | 0.0085 | 0.5227 | 1 |
Schistosoma mansoni | photoreceptor-specific nuclear receptor related | 0.0043 | 0.0975 | 0.0975 |
Entamoeba histolytica | glutamine synthetase, putative | 0.0033 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable glutamine synthetase GlnA2 (glutamine synthase) (GS-II) | 0.0085 | 0.5227 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0064 | 0.3137 | 0.2396 |
Schistosoma mansoni | Tr4/Tr2 (homologue) | 0.0043 | 0.0975 | 0.0975 |
Mycobacterium ulcerans | glutamine synthetase | 0.0085 | 0.5227 | 1 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0064 | 0.3137 | 0.5085 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | < 50 % | Displacement of [3H]ZM241385 from human recombinant adenosine A2A receptor expressed in CHO cells at 1 uM | ChEMBL. | 17028066 |
Inhibition (binding) | < 50 % | Displacement of [3H]NECA from human recombinant adenosine A3 receptor expressed in CHO cells at 1 uM | ChEMBL. | 17028066 |
Inhibition (binding) | < 50 % | Displacement of [3H]ZM241385 from human recombinant adenosine A2A receptor expressed in CHO cells at 1 uM | ChEMBL. | 17028066 |
Inhibition (binding) | < 50 % | Displacement of [3H]NECA from human recombinant adenosine A3 receptor expressed in CHO cells at 1 uM | ChEMBL. | 17028066 |
Ki (binding) | = 1.1024 | Binding affinity to bovine adenosine A1 receptor | ChEMBL. | 17418915 |
Ki (binding) | = 79 nM | Displacement of [3H]DPCPX from bovine cerbral cortex adenosine A1 receptor | ChEMBL. | 17028066 |
Ki (binding) | = 79 nM | Displacement of [3H]DPCPX from bovine cerbral cortex adenosine A1 receptor | ChEMBL. | 17028066 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.